These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 30561809)

  • 61. In vivo safety profile and biodistribution of GMP-manufactured human skin-derived ABCB5-positive mesenchymal stromal cells for use in clinical trials.
    Tappenbeck N; Schröder HM; Niebergall-Roth E; Hassinger F; Dehio U; Dieter K; Kraft K; Kerstan A; Esterlechner J; Frank NY; Scharffetter-Kochanek K; Murphy GF; Orgill DP; Beck J; Frank MH; Ganss C; Kluth MA
    Cytotherapy; 2019 May; 21(5):546-560. PubMed ID: 30878384
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mesenchymal stem cell therapy for the treatment of inflammatory diseases: Challenges, opportunities, and future perspectives.
    Regmi S; Pathak S; Kim JO; Yong CS; Jeong JH
    Eur J Cell Biol; 2019 Dec; 98(5-8):151041. PubMed ID: 31023504
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.
    Kim MJ; Shin KS; Jeon JH; Lee DR; Shim SH; Kim JK; Cha DH; Yoon TK; Kim GJ
    Cell Tissue Res; 2011 Oct; 346(1):53-64. PubMed ID: 21987220
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biological Aspects and Clinical Applications of Mesenchymal Stem Cells: Key Features You Need to be Aware of.
    Saeedi M; Nezhad MS; Mehranfar F; Golpour M; Esakandari MA; Rashmeie Z; Ghorbani M; Nasimi F; Hoseinian SN
    Curr Pharm Biotechnol; 2021; 22(2):200-215. PubMed ID: 32895040
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization and Therapeutic Application of Mesenchymal Stem Cells with Neuromesodermal Origin from Human Pluripotent Stem Cells.
    Wang H; Li D; Zhai Z; Zhang X; Huang W; Chen X; Huang L; Liu H; Sun J; Zou Z; Fan Y; Ke Q; Lai X; Wang T; Li X; Shen H; Xiang AP; Li W
    Theranostics; 2019; 9(6):1683-1697. PubMed ID: 31037131
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparative Characterization of Ischemia-Induced Brain Multipotent Stem Cells with Mesenchymal Stem Cells: Similarities and Differences.
    Sakuma R; Takahashi A; Nakano-Doi A; Sawada R; Kamachi S; Beppu M; Takagi T; Yoshimura S; Matsuyama T; Nakagomi T
    Stem Cells Dev; 2018 Oct; 27(19):1322-1338. PubMed ID: 29999479
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Exosomes Derived from Hypoxia-Treated Human Adipose Mesenchymal Stem Cells Enhance Angiogenesis Through the PKA Signaling Pathway.
    Xue C; Shen Y; Li X; Li B; Zhao S; Gu J; Chen Y; Ma B; Wei J; Han Q; Zhao RC
    Stem Cells Dev; 2018 Apr; 27(7):456-465. PubMed ID: 29415626
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mesenchymal Stem Cells and their Exosomes: Promising Therapeutics for Chronic Pain.
    Ren J; Liu N; Sun N; Zhang K; Yu L
    Curr Stem Cell Res Ther; 2019; 14(8):644-653. PubMed ID: 31512998
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chondrogenic differentiation of synovial fluid mesenchymal stem cells on human meniscus-derived decellularized matrix requires exogenous growth factors.
    Liang Y; Idrees E; Szojka ARA; Andrews SHJ; Kunze M; Mulet-Sierra A; Jomha NM; Adesida AB
    Acta Biomater; 2018 Oct; 80():131-143. PubMed ID: 30267878
    [TBL] [Abstract][Full Text] [Related]  

  • 70. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
    Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C
    Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Adult mesenchymal stem cells: a pluripotent population with multiple applications.
    Porada CD; Zanjani ED; Almeida-Porad G
    Curr Stem Cell Res Ther; 2006 Sep; 1(3):365-9. PubMed ID: 18220880
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease.
    Yun CW; Lee SH
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813471
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tissue source determines the differentiation potentials of mesenchymal stem cells: a comparative study of human mesenchymal stem cells from bone marrow and adipose tissue.
    Xu L; Liu Y; Sun Y; Wang B; Xiong Y; Lin W; Wei Q; Wang H; He W; Wang B; Li G
    Stem Cell Res Ther; 2017 Dec; 8(1):275. PubMed ID: 29208029
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The genes involved in asthma with the treatment of human embryonic stem cell-derived mesenchymal stem cells.
    Lin YD; Fan XL; Zhang H; Fang SB; Li CL; Deng MX; Qin ZL; Peng YQ; Zhang HY; Fu QL
    Mol Immunol; 2018 Mar; 95():47-55. PubMed ID: 29407576
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Scalable Generation of Mesenchymal Stem Cells from Human Embryonic Stem Cells in 3D.
    Yan L; Jiang B; Li E; Wang X; Ling Q; Zheng D; Park JW; Chen X; Cheung E; Du X; Li Y; Cheng G; He E; Xu RH
    Int J Biol Sci; 2018; 14(10):1196-1210. PubMed ID: 30123069
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy.
    Phinney DG
    Cell Cycle; 2007 Dec; 6(23):2884-9. PubMed ID: 18000405
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.
    Moraghebi R; Kirkeby A; Chaves P; Rönn RE; Sitnicka E; Parmar M; Larsson M; Herbst A; Woods NB
    Stem Cell Res Ther; 2017 Aug; 8(1):190. PubMed ID: 28841906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.